May 28, 2026
Important Information
This material is provided for general informational purposes and contains general investment opinions. It does not constitute individualized investment advice and does not consider any reader’s investment objectives, financial circumstances, tax situation or risk tolerance. Investing involves risk, including possible loss of principal. No investment outcome is guaranteed.
Value87-managed client accounts held positions in certain securities discussed in this communication as of the publication date. Other securities are referenced for market commentary, historical analysis or comparative purposes and may not be held in Value87-managed client accounts.
Value87, its personnel and their family members may also hold or transact in securities discussed, subject to applicable policies. These interests create potential conflicts because Value87, its clients or its personnel may benefit if the securities increase in value. Value87 may change its views or transact in these securities without notifying readers.
About the Author
John Buckingham
With 40 years of investment experience, John is the Editor-in-Chief of A Patient Prospector. A former Editor of The Prudent Speculator, he is a recognized Value-investing professional featured in Barron’s, WSJ, CNBC, Bloomberg and Forbes.
Explore
A low stock price can be very tempting. A company trading at 8x earnings might be even more...
Welcome to A Patient Prospector! I’m John Buckingham, Editor-in-Chief and co-founding Executive...
This is our signature publication, offering a monthly perspective on the markets beyond the...
There is never a shortage of market news. We might think there’s too much. Every week brings...
If our Market Observations tell you what we are thinking, our Stock Pick list shows you our...